HB 684 requires health insurance companies to notify members 60 days in advance if a provider (including primary care or behavioral health providers) is removed from their network, unless termination relates to fraud, abuse, or licensure issues. It mandates that members affected by such changes receive a 90-day special enrollment period to continue seeing those providers, along with clear contact information for filing complaints. Insurance companies must also notify the Maryland Insurance Commissioner about network changes at least 60 days before termination and update their access plans within 5 business days of the change. This bill directly affects health insurance members who lose provider access and requires insurers to follow specific transparency and transition procedures.
HB 671 requires Maryland's Governor to allocate at least 3% of funds collected from a Medicaid quality assessment on qualifying nursing facilities (45+ beds operating in the state) to fund the Office of the Long-Term Care Ombudsman starting in fiscal year 2027. This directly affects nursing facilities that pay the assessment and ensures dedicated, supplemental funding for the Ombudsman office, which advocates for residents' rights in long-term care settings. The bill updates existing law to mandate this specific allocation from the assessment pool, specifying that these funds must be "in addition to" and not replace existing Ombudsman funding. It does not change the assessment rate (capped at 6% of facility revenue) or the reporting requirements for the Department.
SB 340 requires the Governor to allocate at least 3% of funds collected from nursing facilities' Medicaid quality assessments toward the Office of the Long-Term Care Ombudsman's operations in the state budget. It directly affects nursing facilities with 45 or more beds operating in Maryland, which must pay the quality assessment. The bill mandates that these funds - collected quarterly based on non-Medicare patient days - must be used solely for the Ombudsman office, with no reduction to existing funding for this purpose. This creates a dedicated, ongoing funding source to support the Ombudsman's role in investigating resident complaints and advocating for long-term care rights.
This bill requires Maryland hospitals to screen patients in emergency departments for pregnancy-related medical emergencies. If a patient has such a condition, hospitals must stabilize it through appropriate treatment - including pregnancy termination when medically necessary - before transferring them, and cannot transfer unstable patients without following federal emergency transfer rules. It prohibits hospitals from retaliating against staff who refuse transfers of unstable patients or report violations, and imposes civil penalties (up to $50,000) for noncompliance. The law applies to all Maryland hospitals and aims to ensure timely, stable care for pregnant patients in medical crises.
This bill establishes the Maryland Advanced Manufacturing Grant Program within the Maryland Technology Development Corporation to support companies specializing in regenerative medicine and other advanced manufacturing sectors. The program will provide grants that recipients can use exclusively for acquiring or renovating manufacturing space, improving infrastructure, and purchasing necessary equipment. A dedicated fund will be created to hold grant money, with interest earnings credited back to the fund rather than the state's general fund. The Corporation will work with the Maryland Stem Cell Research Commission to set eligibility criteria, application procedures, and award amounts, with the program taking effect on July 1, 2026.
HB 1372 requires the Maryland Health Care Commission, working with the Office of Health Care Quality, to create a process for publishing health facility inspection data (including inspection dates, quality ratings, next inspection dates, and compliance statements) on a public website. It establishes the Maryland Department of Health Centralization Commission, composed of legislators, department officials, and health board leaders, to advise on improving efficiency between the Department and health occupations boards. The bill also mandates that all health occupations boards meet minimum cybersecurity standards set by the Secretary of Information Technology. These changes directly affect health care facilities subject to inspections, health occupations boards, and the Maryland Department of Health.
HB 1420 requires criminal history background checks for applicants and renewing licensees in specific healthcare professions, including nursing, dentistry, pharmacy, and others listed in the bill. Starting July 1, 2027, new applicants must submit fingerprints and pay fees to the state’s Central Repository for a criminal records check under new Section 1A-302.1. Existing licensees renewing after January 1, 2028, must also provide proof of a criminal check. The bill establishes standardized procedures for conducting these checks while ensuring confidentiality and allowing applicants to contest results.
HB 625 shifts responsibility for collecting fees from research facilities to the Maryland Department of Agriculture, replacing the current system under the Department of Health. It requires facilities submitting USDA Form 7023 (for animal testing) to pay annual contributions based on animal count: $5,000 for ≤100 animals, $10,000 for 101-500, $55,000 for 501-5,000, and $75,000 for over 5,000. Funds collected will support the Human-Relevant Research Fund established under Maryland’s Economic Development Article. The bill repeals existing health code provisions and creates new agriculture code sections for this fee structure, effective October 2026.
SB 555 establishes the Dementia Services and Brain Health Program within the Maryland Department of Health to lead state public health efforts for brain health and dementia care. The bill shifts responsibilities from a "Director" position to this new Program, requiring it to staff the Virginia I. Jones Alzheimer’s Council, oversee implementation of the State Plan on dementia, and develop a clinical toolkit for healthcare providers. The toolkit will provide evidence-based guidance to help providers deliver person-centered dementia care across medical settings. This bill directly affects Maryland residents living with dementia or at risk, healthcare providers who will use the toolkit, and the Council’s operations.
SB 742, the "Maryland Protecting People With Disabilities Act," modifies Maryland’s Medicaid eligibility processes to better protect individuals with disabilities who receive home- and community-based services. It extends the appeal timeframe for those losing eligibility and requires services to continue uninterrupted during appeals, preventing administrative errors from causing abrupt service loss. The bill prohibits "procedural disenrollment" (terminating coverage due to renewal process issues) and mandates the Department of Health to reserve waiver slots for people who lost eligibility unfairly. These changes align with the Olmstead decision, ensuring individuals can remain in community settings without unnecessary bureaucratic barriers. The bill directly affects Maryland Medicaid recipients with disabilities who rely on home- and community-based services.
